Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.
Ellis J, van Maurik A, Fortunato L, Gisbert S, Chen K, Schwartz A, McHugh S, Want A, Santos Franco S, Oliveira JJ, Price J, Coles A, Brown K, Su D, Craigen JL, Yang J, Brett S, Davis B, Cheriyan J, Kousin-Ezewu O, Gray F, Thompson PW, Fernando D. Ellis J, et al. Among authors: coles a. Br J Clin Pharmacol. 2019 Feb;85(2):304-315. doi: 10.1111/bcp.13748. Epub 2018 Dec 3. Br J Clin Pharmacol. 2019. PMID: 30161291 Free PMC article. Clinical Trial.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Tuohy O, Costelloe L, Hill-Cawthorne G, Bjornson I, Harding K, Robertson N, May K, Button T, Azzopardi L, Kousin-Ezewu O, Fahey MT, Jones J, Compston DA, Coles A. Tuohy O, et al. Among authors: coles a. J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):208-15. doi: 10.1136/jnnp-2014-307721. Epub 2014 May 21. J Neurol Neurosurg Psychiatry. 2015. PMID: 24849515 Clinical Trial.
A case of anaphylaxis to alemtuzumab.
Nye CJS, Wagner A, Kousin-Ezewu O, Jones JL, Coles AJ. Nye CJS, et al. Among authors: coles aj. J Neurol. 2019 Mar;266(3):780-781. doi: 10.1007/s00415-019-09214-2. Epub 2019 Feb 4. J Neurol. 2019. PMID: 30715557 No abstract available.
Keratinocyte growth factor impairs human thymic recovery from lymphopenia.
Coles AJ, Azzopardi L, Kousin-Ezewu O, Mullay HK, Thompson SA, Jarvis L, Davies J, Howlett S, Rainbow D, Babar J, Sadler TJ, Brown JWL, Needham E, May K, Georgieva ZG, Handel AE, Maio S, Deadman M, Rota I, Holländer G, Dawson S, Jayne D, Seggewiss-Bernhardt R, Douek DC, Isaacs JD, Jones JL. Coles AJ, et al. JCI Insight. 2019 May 7;5(12):e125377. doi: 10.1172/jci.insight.125377. JCI Insight. 2019. PMID: 31063156 Free PMC article. Clinical Trial.
CAMPATH-IH in multiple sclerosis.
Moreau T, Coles A, Wing M, Thorpe J, Miller D, Moseley I, Issacs J, Hale G, Clayton D, Scolding N, Waldmann H, Compston A. Moreau T, et al. Among authors: coles a. Mult Scler. 1996 Jul;1(6):357-65. doi: 10.1177/135245859600100616. Mult Scler. 1996. PMID: 9345418
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
Hill-Cawthorne GA, Button T, Tuohy O, Jones JL, May K, Somerfield J, Green A, Giovannoni G, Compston DA, Fahey MT, Coles AJ. Hill-Cawthorne GA, et al. Among authors: coles aj. J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):298-304. doi: 10.1136/jnnp-2011-300826. Epub 2011 Nov 5. J Neurol Neurosurg Psychiatry. 2012. PMID: 22056965
The outlook for alemtuzumab in multiple sclerosis.
Williams T, Coles A, Azzopardi L. Williams T, et al. Among authors: coles a. BioDrugs. 2013 Jun;27(3):181-9. doi: 10.1007/s40259-013-0028-3. BioDrugs. 2013. PMID: 23558379
Alemtuzumab treatment of multiple sclerosis.
Coles AJ. Coles AJ. Semin Neurol. 2013 Feb;33(1):66-73. doi: 10.1055/s-0033-1343797. Epub 2013 May 25. Semin Neurol. 2013. PMID: 23709214 Review.
302 results